Alyeska Investment Group, L.P.

Position in TNGX — Tango Therapeutics, Inc.

CIK 1453072 CHICAGO, IL

Position in TNGX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$21,604,067

+$21,244,285 QoQ

Shares Held

691,109

+3918.5% QoQ

Ownership

0.410%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#50

of 247 holders

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. TNGX ranks #12 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	659,279	$123,469,771
2	IONS	Ionis Pharmaceuticals Inc	1,417,916	$112,426,559
3	PTGX	Protagonist Therapeutics, Inc	889,298	$109,010,148
4	XENE	Xenon Pharmaceuticals Inc.	697,692	$42,112,689
5	MRNA	Moderna, Inc.	560,819	$39,274,154
6	KYMR	Kymera Therapeutics, Inc.	276,455	$31,701,094
7	LBRX	Lb Pharmaceuticals Inc	863,947	$28,039,399
8	PRAX	Praxis Precision Medicines, Inc.	80,846	$27,066,432

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$21,604,067	691,109	+3918.5%	Shares	Sole	2026-08-14
2026-03-31	$359,782	17,198	-76.9%	Shares	Sole	2026-05-15
2023-06-30	$246,802	74,338	0.0%	Shares	Sole	2023-08-14
2023-03-31	$293,635	74,338	0.0%	Shares	Sole	2023-05-15
2022-12-31	$538,950	74,338	0.0%	Shares	Sole	2023-02-14
2022-09-30	$269,103	74,338	0.0%	Shares	Sole	2022-11-14
2022-06-30	$336,751	74,338	0.0%	Shares	Sole	2022-08-15
2022-03-31	$563,482	74,338	-40.2%	Shares	Sole	2022-05-17
2021-12-31	$1,360,257	124,338	-70.7%	Shares	Sole	2022-02-14
2021-09-30	$5,490,569	424,638	—	Shares	Sole	2021-11-15
2021-06-30 BCTG	—	434,093	-1.9%	Shares	Sole	2021-08-16
2021-03-31 BCTG	—	442,312	-11.5%	Shares	Sole	2021-05-17
2020-12-31 BCTG	—	500,000	-0.8%	Shares	Sole	2021-02-16
2020-09-30 BCTG	—	504,000	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.